Linneah sat at a desk at the Center for Sexual Medicine at Sheppard Pratt in the suburbs of Baltimore and filled out a questionnaire. She read briskly, making swift checks beside her selected answers, and when she was finished, she handed the pages across the desk to Martina Miller, who gave her a round of pills.
The pills were either a placebo or a new drug called Lybrido, created to stoke sexual desire in women. Checking her computer, Miller pointed out gently that Linneah hadn't been doing her duty as a study participant. Over the past eight weeks, she took the tablets before she planned to have sex, and for every time she put a pill on her tongue, she was supposed to make an entry in her online diary about her level of lust.